Kevin J. McCallion - 10 Apr 2026 Form 4 Insider Report for 908 Devices Inc. (MASS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Apr 2026, 16:00:05 UTC
Prior SEC filing
10 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark S. Levine, Attorney-in-Fact

Key filing fact

Kevin J. McCallion filed Form 4 for 908 Devices Inc. (MASS) on 14 Apr 2026.

Key facts

  • This page summarizes Kevin J. McCallion's Form 4 filing for 908 Devices Inc. (MASS).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Apr 2026, 16:00.

Change

  • Previous filing in this sequence was filed on 10 Apr 2026.
  • Current net transaction value: -$18,878.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002115341 Primary reporting owner

McCallion Kevin J.

Relationship
SVP, Products and Production
Address
C/O 908 DEVICES INC., 44 3RD AVENUE, BURLINGTON
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Signature date
14 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MASS transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,693
Change %
+6%
Price
$1.05*
Shares after
47,618
Date
10 Apr 2026
Ownership
Direct
Footnotes
F1
MASS transaction

Common Stock

Sale

Transaction value
$18,878
Shares
-2,693
Change %
-5.7%
Price
$7.01
Shares after
44,925
Date
10 Apr 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MASS transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-2,693
Change %
-100%
Price
$0.000000*
Shares after
0
Date
10 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,693
Exercise price
$1.05
Footnotes
F1, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.03 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The shares underlying the option are fully vested and immediately exercisable.

Footnote F4

Due to a scrivener's error on the Form 3, the number of stock options beneficially owned by the Reporting Person pursuant to this grant was understated by 7. Following this transaction, the entire option grant has been exercised.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .